mAb Das-1 is specific for high-risk and malignant intraductal papillary mucinous neoplasm (IPMN).

PubWeight™: 0.83‹?›

🔗 View Article (PMID 24277729)

Published in Gut on November 25, 2013

Authors

Koushik K Das1, Hong Xiao2, Xin Geng3, Carlos Fernandez-Del-Castillo4, Vicente Morales-Oyarvide5, Ebubekir Daglilar6, David G Forcione6, Brenna C Bounds6, William R Brugge6, Martha B Pitman2, Mari Mino-Kenudson2, Kiron M Das3

Author Affiliations

1: Department of Internal Medicine, Massachusetts General Hospital & Harvard Medical School, Boston, Massachusetts, USA.
2: Department of Pathology, Massachusetts General Hospital & Harvard Medical School, Boston, Massachusetts, USA.
3: Division of Gastroenterology, Rutgers-Robert Wood Johnson Medical School, New Brunswick, New Jersey, USA.
4: Department of Surgery, Massachusetts General Hospital & Harvard Medical School, Boston, Massachusetts, USA.
5: Department of Pathology, Massachusetts General Hospital & Harvard Medical School, Boston, Massachusetts, USA Department of Surgery, Massachusetts General Hospital & Harvard Medical School, Boston, Massachusetts, USA.
6: Division of Gastroenterology, Massachusetts General Hospital & Harvard Medical School, Boston, Massachusetts, USA.

Articles cited by this

International consensus guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas. Pancreatology (2006) 8.83

International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas. Pancreatology (2012) 7.22

Intraductal papillary mucinous neoplasms of the pancreas: an updated experience. Ann Surg (2004) 5.12

Main-duct intraductal papillary mucinous neoplasms of the pancreas: clinical predictors of malignancy and long-term survival following resection. Ann Surg (2004) 5.09

Prevalence of unsuspected pancreatic cysts on MDCT. AJR Am J Roentgenol (2008) 4.70

Pancreatic cyst fluid DNA analysis in evaluating pancreatic cysts: a report of the PANDA study. Gastrointest Endosc (2009) 3.32

Classification of types of intraductal papillary-mucinous neoplasm of the pancreas: a consensus study. Virchows Arch (2005) 2.76

Study of recurrence after surgical resection of intraductal papillary mucinous neoplasm of the pancreas. Gastroenterology (2002) 2.76

Mutant GNAS detected in duodenal collections of secretin-stimulated pancreatic juice indicates the presence or emergence of pancreatic cysts. Gut (2012) 2.17

miRNA biomarkers in cyst fluid augment the diagnosis and management of pancreatic cysts. Clin Cancer Res (2012) 2.10

Mutant TP53 in duodenal samples of pancreatic juice from patients with pancreatic cancer or high-grade dysplasia. Clin Gastroenterol Hepatol (2012) 1.99

Prognosis of invasive intraductal papillary mucinous neoplasm depends on histological and precursor epithelial subtypes. Gut (2011) 1.94

Mucin-producing neoplasms of the pancreas: an analysis of distinguishing clinical and epidemiologic characteristics. Clin Gastroenterol Hepatol (2009) 1.90

Prognosis of malignant intraductal papillary mucinous tumours of the pancreas after surgical resection. Comparison with pancreatic ductal adenocarcinoma. Gut (2002) 1.85

Do consensus indications for resection in branch duct intraductal papillary mucinous neoplasm predict malignancy? A study of 147 patients. Am J Gastroenterol (2007) 1.83

Evaluation of the guidelines for management of pancreatic branch-duct intraductal papillary mucinous neoplasm. Clin Gastroenterol Hepatol (2008) 1.82

Intraductal oncocytic papillary neoplasms of the pancreas. Am J Surg Pathol (1996) 1.82

The production and characterization of monoclonal antibodies to a human colonic antigen associated with ulcerative colitis: cellular localization of the antigen by using the monoclonal antibody. J Immunol (1987) 1.58

Epithelial deposits of immunoglobulin G1 and activated complement colocalise with the M(r) 40 kD putative autoantigen in ulcerative colitis. Gut (1993) 1.50

Colloid (mucinous noncystic) carcinoma of the pancreas. Am J Surg Pathol (2001) 1.40

Single-institution validation of the international consensus guidelines for treatment of branch duct intraductal papillary mucinous neoplasms of the pancreas. J Hepatobiliary Pancreat Surg (2009) 1.17

Intraductal papillary mucinous neoplasms of the pancreas. Gastroenterology (2010) 1.13

Cytology from pancreatic cysts has marginal utility in surgical decision-making. Ann Surg Oncol (2008) 1.13

Invasive cancer and survival of intraductal papillary mucinous tumors of the pancreas. Am J Gastroenterol (2002) 1.12

Cytology adds value to imaging studies for risk assessment of malignancy in pancreatic mucinous cysts. Ann Surg (2011) 1.05

Characteristic clinicopathological features of the types of intraductal papillary-mucinous neoplasms of the pancreas. Pancreas (2007) 1.04

Phenotypic differences between esophageal and gastric intestinal metaplasia. Mod Pathol (2004) 1.04

Development of pancreatic cancers during long-term follow-up of side-branch intraductal papillary mucinous neoplasms. Endoscopy (2010) 0.99

Plectin-1 is a biomarker of malignant pancreatic intraductal papillary mucinous neoplasms. J Gastrointest Surg (2009) 0.98

Detection of a shared colon epithelial epitope on Barrett epithelium by a novel monoclonal antibody. Ann Intern Med (1994) 0.96

Intraductal papillary mucinous tumor of the pancreas. Gastrointest Endosc (2002) 0.95

Use of a novel monoclonal antibody in diagnosis of Barrett's esophagus. Dig Dis Sci (2000) 0.92

Biomarkers predicting development of metachronous gastric cancer after endoscopic resection: an analysis of molecular pathology of Helicobacter pylori eradication. Int J Cancer (2011) 0.90

Cytological analysis of small branch-duct intraductal papillary mucinous neoplasms provides a more accurate risk assessment of malignancy than symptoms. Cytojournal (2011) 0.89

Repeated exposure to acid and bile selectively induces colonic phenotype expression in a heterogeneous Barrett's epithelial cell line. Lab Invest (2008) 0.88

Gastric intestinal metaplasia as detected by a monoclonal antibody is highly associated with gastric adenocarcinoma. Gut (2003) 0.85

Fluid analysis prior to surgical resection of suspected mucinous pancreatic cysts. A single centre experience. J Gastrointest Oncol (2011) 0.84

An antigen reacting with das-1 monoclonal antibody is ontogenically regulated in diverse organs including liver and indicates sharing of developmental mechanisms among cell lineages. Pathobiology (2000) 0.84

Externalization of tropomyosin isoform 5 in colon epithelial cells. Clin Exp Immunol (1999) 0.80

A phenotypic change of small intestinal epithelium to colonocytes in small intestinal adenomas and adenocarcinomas. Am J Gastroenterol (2001) 0.78

The monoclonal antibody 7E12H12 can differentiate primary adenocarcinoma of the bladder and prostate. Br J Urol (1998) 0.78